Ir para conteúdo

Oncologia

Abordagem Individualizada, Interdisciplinar e Multimodal

Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's Witness: a strategy to avoid transfusion. (abre uma nova janela)

Barakat O, Cooper JR Jr, Riggs SA, Hoef JW, Ozaki CF, Wood RP.

Fonte‎: J Surg Oncol 2007;96(3):249-53.

Indexado‎: PubMed 17443725

DOI‎: 10.1002/jso.20799

https://www.ncbi.nlm.nih.gov/pubmed/17443725 (abre uma nova janela)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (abre uma nova janela)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Fonte‎: Transfusion 2016;56(10):2438-42.

Indexado‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (abre uma nova janela)

Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. (abre uma nova janela)

Gross I, Trentino KM, Andreescu A, Pierson R, Maietta RA, Farmer S.

Fonte‎: Oncologist 2016;21(3):327-32.

Indexado‎: PubMed 26865590

DOI‎: 10.1634/theoncologist.2015-0406

https://www.ncbi.nlm.nih.gov/pubmed/26865590 (abre uma nova janela)

Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (abre uma nova janela)

Konstantinidis IT, Allen PJ, D'Angelica MI, Dematteo RP, Fischer ME, Grant F, Fong Y, Kingham TP, Jarnagin WR.

Fonte‎: J Am Coll Surg 2013;217(6):1101-7.

Indexado‎: PubMed 23880361

DOI‎: 10.1016/j.jamcollsurg.2013.05.020

https://www.ncbi.nlm.nih.gov/pubmed/23880361 (abre uma nova janela)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (abre uma nova janela)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Fonte‎: Leuk Res Rep. 2022 25;18:100355.

Indexado‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (abre uma nova janela)